Insurance News
Regulatory updates in plain English
Stay current with the latest from CMS, state departments of insurance, NAIC, the Federal Register, and Congress — rewritten so you can actually understand what it means for your practice.
CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation
The Centers for Medicare & Medicaid Services (CMS) has announced that drug manufacturers will participate in the third round of negotiations for Medicare drug prices. This change affects pharmaceutical companies that provide medications covered under Medicare. Agents should stay informed about these...
CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation
The Centers for Medicare & Medicaid Services (CMS) has announced that drug companies are participating in the third round of negotiations for Medicare drug prices. This affects 15 specific high-cost drugs that are covered under Medicare Part B and Part D. These negotiations aim to lower the prices o...
CMS Proposed Rule Locks in Lower Prices and Fosters Innovation for the Medicare Drug Price Negotiation Program
The Centers for Medicare & Medicaid Services (CMS) has proposed a new rule to create a permanent system for negotiating drug prices for Medicare beneficiaries. This change aims to lower drug costs and provide more stability for drug manufacturers involved in these negotiations. Starting in 2029, CMS...
Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
The Medicare Drug Price Negotiation Program is being officially established, along with new policies for the Medicare Prescription Drug Benefit Program. This change is part of the Inflation Reduction Act of 2022. Additionally, there will be updates to the rules regarding fixed combination drugs. Ins...